Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[CAD is associated with reduced vascular responses to both VEGF and HGF; this is not likely due to a reduced expression of VEGF or flt-1 or flk-1 receptors and not due to a generalized endothelium dysfunction despite the presence of mild hypercholesterolemia in these patients with CAD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP529371.RAxvg_ulrJOVLVwVfW7yLYivS3HnZ2cMLdb2JJLUHxBCo130_assertion description "[CAD is associated with reduced vascular responses to both VEGF and HGF; this is not likely due to a reduced expression of VEGF or flt-1 or flk-1 receptors and not due to a generalized endothelium dysfunction despite the presence of mild hypercholesterolemia in these patients with CAD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP529371.RAxvg_ulrJOVLVwVfW7yLYivS3HnZ2cMLdb2JJLUHxBCo130_provenance.
• NP650551.RAwXlaL0qLF3eaQv3JCuW-Ei9tzsc-V-9Zb7fHlXbu5rs130_assertion description "[CAD is associated with reduced vascular responses to both VEGF and HGF; this is not likely due to a reduced expression of VEGF or flt-1 or flk-1 receptors and not due to a generalized endothelium dysfunction despite the presence of mild hypercholesterolemia in these patients with CAD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650551.RAwXlaL0qLF3eaQv3JCuW-Ei9tzsc-V-9Zb7fHlXbu5rs130_provenance.
• NP523643.RAnnh719NYIZXAV3jQnFnBW0YJdlRg8zhHZKQs1vu2UCc130_assertion description "[CAD is associated with reduced vascular responses to both VEGF and HGF; this is not likely due to a reduced expression of VEGF or flt-1 or flk-1 receptors and not due to a generalized endothelium dysfunction despite the presence of mild hypercholesterolemia in these patients with CAD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP523643.RAnnh719NYIZXAV3jQnFnBW0YJdlRg8zhHZKQs1vu2UCc130_provenance.
• NP524068.RAlIMyVr_yB_aNz61qyq7J1Mkc2Rn0IwRYsrN19ONd9ww130_assertion description "[CAD is associated with reduced vascular responses to both VEGF and HGF; this is not likely due to a reduced expression of VEGF or flt-1 or flk-1 receptors and not due to a generalized endothelium dysfunction despite the presence of mild hypercholesterolemia in these patients with CAD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524068.RAlIMyVr_yB_aNz61qyq7J1Mkc2Rn0IwRYsrN19ONd9ww130_provenance.
• NP1404373.RAZ_AbtRkYxLIafydEeyMlrOAiQpAFSWROOizyaCMh8Kw130_assertion description "[CAD is associated with reduced vascular responses to both VEGF and HGF; this is not likely due to a reduced expression of VEGF or flt-1 or flk-1 receptors and not due to a generalized endothelium dysfunction despite the presence of mild hypercholesterolemia in these patients with CAD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1404373.RAZ_AbtRkYxLIafydEeyMlrOAiQpAFSWROOizyaCMh8Kw130_provenance.
• NP407801.RAl02CqTXq_dRkSiuhoAElUxXIZ1z-p52EcVHBCvOsK6k130_assertion description "[CAD is associated with reduced vascular responses to both VEGF and HGF; this is not likely due to a reduced expression of VEGF or flt-1 or flk-1 receptors and not due to a generalized endothelium dysfunction despite the presence of mild hypercholesterolemia in these patients with CAD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP407801.RAl02CqTXq_dRkSiuhoAElUxXIZ1z-p52EcVHBCvOsK6k130_provenance.
• NP770416.RA413XRoZ60AujknC7p8rdomCspbYpHvZft6yRoYa32AA130_assertion description "[CAD is associated with reduced vascular responses to both VEGF and HGF; this is not likely due to a reduced expression of VEGF or flt-1 or flk-1 receptors and not due to a generalized endothelium dysfunction despite the presence of mild hypercholesterolemia in these patients with CAD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP770416.RA413XRoZ60AujknC7p8rdomCspbYpHvZft6yRoYa32AA130_provenance.
• NP1404370.RAFBsZ5ygStlpeIFokH8x1clCwqBsJeaW2VEgY1J44UyU130_assertion description "[CAD is associated with reduced vascular responses to both VEGF and HGF; this is not likely due to a reduced expression of VEGF or flt-1 or flk-1 receptors and not due to a generalized endothelium dysfunction despite the presence of mild hypercholesterolemia in these patients with CAD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1404370.RAFBsZ5ygStlpeIFokH8x1clCwqBsJeaW2VEgY1J44UyU130_provenance.
• NP1404372.RAJTQalXRvID1V3GI4sX2APrr9cFN_tXnHBZjC-XrCORw130_assertion description "[CAD is associated with reduced vascular responses to both VEGF and HGF; this is not likely due to a reduced expression of VEGF or flt-1 or flk-1 receptors and not due to a generalized endothelium dysfunction despite the presence of mild hypercholesterolemia in these patients with CAD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1404372.RAJTQalXRvID1V3GI4sX2APrr9cFN_tXnHBZjC-XrCORw130_provenance.
• NP1404375.RAI12AbN9b_mju3u0hXCozgLUSAhT_4mGz7k7JBx2Cx6E130_assertion description "[CAD is associated with reduced vascular responses to both VEGF and HGF; this is not likely due to a reduced expression of VEGF or flt-1 or flk-1 receptors and not due to a generalized endothelium dysfunction despite the presence of mild hypercholesterolemia in these patients with CAD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1404375.RAI12AbN9b_mju3u0hXCozgLUSAhT_4mGz7k7JBx2Cx6E130_provenance.